Letter: Early real‐world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease—Authors' reply.

Authors :: Yiu, Tsz Hong
Ko, Yanna
Pudipeddi, Aviv
Natale, Patrizia
Leong, Rupert W.
Source :: Alimentary Pharmacology & Therapeutics. Jul2024, Vol. 60 Issue 1, p103-104. 2p.
Publication Year :: 2024
Abstract: LINKED CONTENT: This article is linked to Yiu et al papers. To view these articles, visit https://doi.org/10.1111/apt.18006 and https://doi.org/10.1111/apt.18049 [ABSTRACT FROM AUTHOR]

Full Text Access

Tools